Calcified lesions

钙化性病变
  • 文章类型: Journal Article
    临床医生早就认识到冠状动脉病变的某些特征增加了干预的复杂性。复杂病变与更差的心血管结局和更高的随后缺血事件风险相关。这些病变根据其血管造影特征进行分类。这些特征包括分叉病变,左冠状动脉主干疾病,钙化病变,支架内再狭窄,慢性完全闭塞和移植干预。这篇由两部分组成的综述旨在强调经皮治疗这些病变的当前证据。本综述的第一部分重点介绍治疗分叉病变的最佳技术,左主干冠状动脉疾病介入治疗的指征和用于治疗钙化病变的其他工具。
    Clinicians have long recognized that certain features of coronary artery lesions increase the complexity of intervention. Complex lesions are associated with worse cardiovascular outcomes and a higher risk of subsequent ischemic events. These lesions are categorized by their angiographic features. These features include bifurcation lesions, left main coronary artery disease, calcified lesions, in-stent restenosis, chronic total occlusions and graft interventions. This two-part review aims to highlight the current evidence in the percutaneous management of these lesions. Part one of this review focuses on the best techniques to treat bifurcation lesions, indications for intervention of left main coronary artery disease and additional tools used to treat calcified lesions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Meta-Analysis
    钙化冠状动脉斑块(CCP)对于介入心脏病学家来说是一个具有挑战性的场景。支架膨胀不足(SU),经常与CCP联系在一起,可能导致支架内血栓形成和支架内再狭窄。迄今为止,可以使用非常高/高压力的非顺应性气球来解决具有严重CCP的SU,标示外旋磨/眼眶旋磨,准分子激光旋切术,和血管内碎石术(IVL)。在这个荟萃分析中,我们调查了IVL治疗因CCP引起的SU的成功率。包括关于使用IVL策略治疗SU的研究和基于病例的经验报告。主要终点是IVL策略成功,定义为扩张不足的支架的充分扩张。对主要焦点进行元分析,以计算手术成功率的比例以及相应的95%置信区间(CI)。由于临床异质性,使用了逆方差加权的随机效应模型。这项荟萃分析包括13项研究,涉及354名患者。平均年龄为71.3岁(95%CI为64.9至73.1),77%(95%CI71.2%至82.4%)为男性。平均随访时间为2.6个月(95%CI1至15.3)。88.7%(95%CI82.3~95.1)的患者策略成功。6项研究报告了平均最小支架面积,IVL前值为3.4mm2(95%CI3至3.8),IVL后值为6.9mm2(95%CI6.5至7.4)。在7项研究中报告了平均直径狭窄(百分比),IVL前值为69.4%(95%CI60.7至78.2),IVL后值为14.6%(95%CI11.1至18)。术中并发症的发生率为1.6%(95%CI0.3至2.9)。总之,“通过支架”IVL斑块修饰技术是治疗CCP引起的SU的安全工具,成功率高,并发症发生率很低。
    Calcified coronary plaque (CCP) represents a challenging scenario for interventional cardiologists. Stent underexpansion (SU), often associated with CCP, can predispose to stent thrombosis and in-stent restenosis. To date, SU with heavily CCP can be addressed using very high-/high-pressure noncompliant balloons, off-label rotational atherectomy/orbital atherectomy, excimer laser atherectomy, and intravascular lithotripsy (IVL). In this meta-analysis, we investigated the success rate of IVL for the treatment of SU because of CCP. Studies and case-based experiences reporting on the use of IVL strategy for treatment of SU were included. The primary end point was IVL strategy success, defined as the adequate expansion of the underexpanded stent. A metanalysis was performed for the main focuses to calculate the proportions of procedural success rates with corresponding 95% confidence intervals (CIs). Random-effects models weighted by inverse variance were used because of clinical heterogeneity. This meta-analysis included 13 studies with 354 patients. The mean age was 71.3 years (95% CI 64.9 to 73.1), and 77% (95% CI 71.2% to 82.4%) were male. The mean follow-up time was 2.6 months (95% CI 1 to 15.3). Strategy success was seen in 88.7% (95% CI 82.3 to 95.1) of patients. The mean minimal stent area was reported in 6 studies, the pre-IVL value was 3.4 mm2 (95% CI 3 to 3.8), and the post-IVL value was 6.9 mm2 (95% CI 6.5 to 7.4). The mean diameter stenosis (percentage) was reported in 7 studies, the pre-IVL value was 69.4% (95% CI 60.7 to 78.2), and the post-IVL value was 14.6% (95% CI 11.1 to 18). The rate of intraprocedural complications was 1.6% (95% CI 0.3 to 2.9). In conclusion, the \"stent-through\" IVL plaque modification technique is a safe tool to treat SU caused by CCP, with a high success rate and a very low incidence of complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Review
    头部和颈部的软组织钙化是相对常见的,并且是多种良性和恶性病变的结果。鉴于广泛的潜在病因,它们可以提出诊断挑战。尿毒症性肿瘤钙质沉着症(UTC)是由转移性软组织钙化引起的终末期肾病(ESRD)的罕见并发症。常见部位包括肩关节周围软组织,肘部,和手(潘和陈,2016)。UTC还可以影响颈椎和模仿骨肉瘤(Zhou等人。,2018)。我们介绍了一个71岁的高血压女性,左颈动脉狭窄,二尖瓣脱垂,和继发于II型糖尿病(DMII)腹膜透析的ESRD,异质,双侧颈部钙化肿块。鉴于她的临床病史,实验室结果,和影像学发现,她被诊断为UTC。除了这个案例,我们提供肿瘤钙质沉着症(TC)的概述和头颈部钙化病变的鉴别诊断.
    Soft-tissue calcifications in the head and neck are relatively common and are the result of a wide variety of benign and malignant pathologies. They can present a diagnostic challenge given the broad range of underlying etiologies. Uremic tumoral calcinosis (UTC) is a rare complication of end-stage renal disease (ESRD) resulting from metastatic soft tissue calcification. Common sites include periarticular soft tissues of the shoulders, elbows, and hands (Pan and Chen, 2016). UTC can also affect the cervical spine and mimic osteosarcomas (Zhou et al., 2018). We present the case of a 71-year-old female with hypertension, left carotid artery stenosis, mitral valve prolapse, and ESRD secondary to diabetes mellitus type II (DMII) on peritoneal dialysis who was found to have large, heterogeneous, bilateral calcified neck masses. Given her clinical history, laboratory results, and imaging findings, she was diagnosed with UTC. In addition to this case, we provide an overview of tumoral calcinosis (TC) and a differential diagnosis for calcified lesions of the head and neck.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    冠状动脉钙化在冠心病中普遍存在,其进展预示着未来的不良心脏事件。它的存在被认为是介入程序复杂性的标志。几种辅助经皮冠状动脉介入治疗工具,比如修改气球,动脉粥样硬化切除术设备和血管内碎石术,目前已成功治疗钙化性病变。在这份最新的审查中,描述了一种逐步进展的策略来修改冠状动脉斑块,从公认的技术到只有在标准操作被证明不成功时才应考虑的技术。在过去的几十年中,技术取得了长足的进步,我们将讨论未来的技术如何塑造经皮介入。
    Coronary artery calcification is prevalent in coronary heart disease with its progression being predictive of future adverse cardiac events. Its presence is considered to be a marker of interventional procedural complexity. Several adjunctive percutaneous coronary intervention tools, such as modifying balloons, atherectomy devices and intravascular lithotripsy, now exist to successfully treat calcified lesions. In this state-of-the-art review, a step-wise progression of strategies is described to modify coronary plaque, from well-recognised techniques to techniques that should only be considered when standard manoeuvres have proven unsuccessful. Technology has advanced greatly over the past few decades and we discuss how future technologies might shape percutaneous intervention.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号